Cargando…
p27(kip1): a target for tumor therapies?
The cyclin kinase inhibitor p27(kip1 )acts as a potent tumor supressor protein in a variety of human cancers. Its expression levels correlate closely with the overall prognosis of the affected patient and often predict the outcome to different treatment modalities. In contrast to other tumor suppres...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1872022/ https://www.ncbi.nlm.nih.gov/pubmed/17488529 http://dx.doi.org/10.1186/1747-1028-2-13 |